glp-1 and cholesterol Glucagon-like peptide-1 receptor agonists improve metabolism by inhibiting SREBP-2 via SIRT6-AMPK pathway in HepG2 cells treated with palmitic acid Research Progress on the Association

2027 to 2028 Commercial launch

In fact, all evidence-based professional guidelines since 2016 have advocated that obesity medications be available in individualized care plans

Structure 21 , 19661978 (2013)

A third incretin-based approach is tirzepatide, a dual agonist of GLP-1R and glucose-dependent insulinotropic polypeptide receptor (GIPR), which achieves greater HbA1c reduction and weight loss compared with GLP-1RAs alone

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.Lancet

doi: 10.1007/s00415-020-09813-4 Summary Keywords glucagon-like peptide-1 receptor agonists, Treg cells, microglia, IL-10, ischemic stroke Citation Sun H, Hao Y, Liu H and Gao F (2025) The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment